ARCH Venture Partners XII, LLC, 10% Owner at Prime Medicine, Inc. (PRME), bought 3,200,000 shares at $6.25 ($20.0M) on 2024-02-15, disclosed to the SEC on 2024-02-20.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| Filing → |
| NMRA | BUY | 2023-11-07 | $1.9M | — | Filing → |